Milford, Massachusetts-based Waters Corporation (WAT) is a leading analytical instruments and life sciences technology company that develops, manufactures, and services laboratory equipment, software, and consumables used in pharmaceutical research, drug development, clinical diagnostics, and food and environmental safety testing. With a market cap of $42.9 billion, the company specializes in liquid chromatography, mass spectrometry, thermal analysis, and rheometry technologies that help scientists identify chemical compounds, measure material properties, and assess product quality.
The global analytical instrumentation leader is expected to announce its fiscal third-quarter earnings for 2026 before the market opens on Tuesday, Nov. 3. Ahead of the event, analysts expect WAT to report a profit of $3.99 per share on a diluted basis, up 17.4% from $3.40 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.